Andy Plump to Retire from Takeda in 2027, Marking the End of a Transformative R&D Era
Andy Plump, the influential President of Research & Development at Takeda Pharmaceutical Company, is set...
Knowledge and News for the Global Fight Against Cancer.
Andy Plump, the influential President of Research & Development at Takeda Pharmaceutical Company, is set...
The landscape of cancer treatment is undergoing a profound transformation, shifting from a generalized approach...
Cardiovascular diseases (CVDs) stand as an unparalleled global health crisis, claiming an estimated 17.9 million...
The first chill of autumn invariably heralds a familiar sight: supermarket shelves overflowing with vitamin...
Dopamine, a powerful brain chemical and neurotransmitter, is a key regulator of many important functions...
A comprehensive mathematical modeling study conducted by researchers at Jena University Hospital in Germany has...
The landscape of pediatric oncology research is frequently defined by clinical breakthroughs and laboratory milestones,...
The clinical landscape of pediatric oncology is often defined by a series of rigorous medical...
In a major advancement for addiction medicine and public health, researchers at Scripps Research have...
The U.S. Food and Drug Administration (FDA) has placed a clinical hold on the RISE-2...